{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:37:17Z","timestamp":1782488237696,"version":"3.54.5"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The aim of this study is to analyse the prevalence, epidemiology, and anticoagulation prevention of stroke or transient ischaemic attack (TIA) in Czech patients with atrial fibrillation (AF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Retrospective observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Healthcare Services between 2015 and 2018. Prevalence of AF in 2018 was 4.3% of Czech population and the prevalence of stroke\/TIA in AF patients was 22.3% with annual incidence of 181.62 cases per 100 000 inhabitants. In 2018, CHA2DS2-ASc score \u22654 was present in 98% AF patients in secondary and 59% in primary prevention, respectively, while the anticoagulation treatment was used by 71\u201381% of them. Between 2015 and 2018, the percentage of AF patients treated with warfarin monotherapy in primary prevention decreased from 35% to 31%, with acetylsalicylic acid (ASA) monotherapy from 18% to 16% and non-vitamin K antagonist oral anticoagulants (NOACs) monotherapy increased from 7% to 11%. In secondary prevention, the percentage of warfarin monotherapy treatment decreased from 35% to 32%, with ASA monotherapy from 20% to 18% and with NOACs monotherapy increased from 9% to 15%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study followed all Czech patients with AF. The unadjusted prevalence and incidence of AF was higher compared with other countries and 2019 European Society of Cardiology Statistics. The study identified several gaps in standard of reimbursed care. 20\u201330% of AF patients with other risk factors were without any prevention medication and the share of ASA monotherapy in treated patients was 16\u201318%.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euaa261","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T19:28:17Z","timestamp":1596569297000},"page":"539-547","source":"Crossref","is-referenced-by-count":4,"title":["SETAP: epidemiology and prevention of stroke and transient ischaemic attack in Czech patients with atrial fibrillation"],"prefix":"10.1093","volume":"23","author":[{"given":"Milo\u0161","family":"T\u00e1borsk\u00fd","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I \u2013 Cardiology, University Hospital Olomouc, Olomouc 775 20, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Du\u0161ek","sequence":"additional","affiliation":[{"name":"Institute of Health Information and Statistics of the Czech Republic, Palack\u00e9ho n\u00e1m. 4, Praha 2 128 01, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Medicine \u2013 IKEM, V\u00edde\u0148sk\u00e1 1958, Praha 4 140 21, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"V\u00edcha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I \u2013 Cardiology, University Hospital Olomouc, Olomouc 775 20, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Aiglov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I \u2013 Cardiology, University Hospital Olomouc, Olomouc 775 20, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edt","family":"Gloger","sequence":"additional","affiliation":[{"name":"Ba\u0165a Regional Hospital, Havl\u00ed\u010dkovo n\u00e1b\u0159. 600, Zl\u00edn 762 75, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1n","family":"Fedorco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I \u2013 Cardiology, University Hospital Olomouc, Olomouc 775 20, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Duba","sequence":"additional","affiliation":[{"name":"OAKS Consulting, Nad Rybn\u00edkem 90, Praha 9 190 12, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk\u00e1\u0161","family":"Du\u0161ek","sequence":"additional","affiliation":[{"name":"OAKS Consulting, Nad Rybn\u00edkem 90, Praha 9 190 12, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Jarkovsk\u00fd","sequence":"additional","affiliation":[{"name":"Institut biostatistiky a anal\u00fdz L\u00e9ka\u0159sk\u00e9 fakulty Masarykovy univerzity, Kamenice, 126, Bohunice 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bezd\u011bkov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Health Information and Statistics of the Czech Republic, Palack\u00e9ho n\u00e1m. 4, Praha 2 128 01, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Sk\u00e1la","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I \u2013 Cardiology, University Hospital Olomouc, Olomouc 775 20, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"2021040708593559200_euaa261-B1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"2021040708593559200_euaa261-B2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2021040708593559200_euaa261-B3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2021040708593559200_euaa261-B4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2021040708593559200_euaa261-B5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"2021040708593559200_euaa261-B6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"2021040708593559200_euaa261-B7","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2021040708593559200_euaa261-B8","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1016\/j.crvasa.2016.11.005","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"58","author":"\u010cih\u00e1k","year":"2016","journal-title":"Cor Vasa"},{"key":"2021040708593559200_euaa261-B9","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"2021040708593559200_euaa261-B10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009586.pub2","article-title":"Effectiveness of systematic screening for the detection of atrial fibrillation","volume":"4","author":"Moran","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/4\/539\/36916900\/euaa261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/4\/539\/36916900\/euaa261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T09:00:24Z","timestamp":1617786024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/23\/4\/539\/6030920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,11]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaa261","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,11]]}}}